← SynDRA
AZD-5423
SynDRA canonical compound SYN0039248 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | BGLAP | NR3C1 |
| Mechanism of action | glucocorticoid receptor modulator |
| Indication | chronic obstructive pulmonary disease (copd) |
| Disease area | pulmonary |
All known targets
Mechanisms of action (all sources)
- NR3C1 MODULATOR
- NR3C1 AGONIST
Cross-references
Synonyms
- AZD5423
- UNII-641H0Q518W
- 641H0Q518W
- 2,2,2-trifluoro-N-[(1R,2S)-1-[1-(4-fluorophenyl)indazol-5-yl]oxy-1-(3-methoxyphenyl)propan-2-yl]acetamide
- 2,2,2-Tris(Fluoranyl)-~{n}-[(1~{r},2~{s})-1-[1-(4-Fluorophenyl)indazol-5-Yl]oxy-1-(3-Methoxyphenyl)propan-2-Yl]ethanamide
- Acetamide, 2,2,2-trifluoro-N-[(1S,2R)-2-[[1-(4-fluorophenyl)-1H-indazol-5-yl]oxy]-2-(3-methoxyphenyl)-1-methylethyl]-;Acetamide, 2,2,2-trifluoro-N-[(1S,2R)-2-[[1-(4-fluorophenyl)-1H-indazol-5-yl]oxy]-2-(3-methoxyphenyl)-1-methylethyl]-
- AZD 5423
- RefChem:560461
- DTXCID5068314
- C25H21F4N3O3
- SCHEMBL524607
- orb1308612
- SCHEMBL29373225
- SCHEMBL29968143
- GTPL13017
- AZD 5423 [WHO-DD]
- GLXC-10781
- EX-A5022
- BDBM50250112
- MFCD26142626
- AKOS040741197
- compound 1b [PMID: 28937774]
- DA-69621
- MS-29055
- HY-108243
- CS-0027671
- NS00073075
- G14284
- T14377
- 8W8
Look up AZD-5423 in the interactive SynDRA portal →